Effect of Intravitreal Methotrexate and Rituximab on Interleukin-10 Levels in Aqueous Humor of Treated Eyes with Vitreoretinal Lymphoma

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Raja, Harish ^a   Snyder, Melissa R ^a   Johnston, Patrick B ^a   O'Neill, Brian P ^a   Caraballo, Juline N ^a   Balsanek, Joseph G ^a   Peters, Brian E ^a   Decker, Paul A ^a   Pulido, Jose S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENDAMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; INTERLEUKIN 10; INTERLEUKIN 6; MELPHALAN; METHOTREXATE; PREDNISONE; RITUXIMAB; TEMOZOLOMIDE; VINCRISTINE SULFATE;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER REGRESSION; CLINICAL ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; DRUG RESPONSE; EYE CANCER; FEMALE; HUMAN; LARGE CELL LYMPHOMA; MALE; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; UVEITIS; VITREORETINAL LYMPHOMA;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; AQUEOUS HUMOR; CHILD; DIAGNOSIS, DIFFERENTIAL; EYE NEOPLASMS; FEMALE; HUMANS; INTERLEUKIN-10; LYMPHOMA; MALE; METHOTREXATE; MIDDLE AGED; UVEITIS; VITREOUS BODY;

EID: 84878628428     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065627     Document Type: Article

References (20)

1. Gunduz K, Pulido JS, McCannel CA, O'Neill BP, (2006) Ocular manifestations and treatment of central nervous system lymphomas. Neurosurgical focus 21: E9.
2. Rajagopal R, Harbour JW, (2011) Diagnostic testing and treatment choices in primary vitreoretinal lymphoma. Retina 31: 435-440.
3. Grimm SA, Pulido JS, Jahnke K, Schiff D, Hall AJ, et al. (2007) Primary intraocular lymphoma: an International Primary Central Nervous System Lymphoma Collaborative Group Report. Annals of oncology: official journal of the European Society for Medical Oncology/ESMO 18: 1851-1855.
4. Itty S, Pulido JS, (2009) Rituximab for intraocular lymphoma. Retina 29: 129-132.
5. Cassoux N, Merle-Beral H, Leblond V, Bodaghi B, Milea D, et al. (2000) Ocular and central nervous system lymphoma: clinical features and diagnosis. Ocular immunology and inflammation 8: 243-250.
6. Chan CC, Whitcup SM, Solomon D, Nussenblatt RB, (1995) Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. American journal of ophthalmology 120: 671-673.
7. Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, et al. (1992) Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 89: 1890-1893.
8. Salazar-Onfray F, (1999) Interleukin-10: a cytokine used by tumors to escape immunosurveillance. Medical oncology 16: 86-94.
9. Whitcup SM, Stark-Vancs V, Wittes RE, Solomon D, Podgor MJ, et al. (1997) Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma. Archives of ophthalmology 115: 1157-1160.
10. Sugita S, Takase H, Sugamoto Y, Arai A, Miura O, et al. (2009) Diagnosis of intraocular lymphoma by polymerase chain reaction analysis and cytokine profiling of the vitreous fluid. Japanese journal of ophthalmology 53: 209-214.
11. Cassoux N, Giron A, Bodaghi B, Tran TH, Baudet S, et al. (2007) IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma. Investigative ophthalmology & visual science 48: 3253-3259.
12. GraphPad Prism version 6.0 for Windows, GraphPad Software, La Jolla California USA. Available: www.graphpad.com. Accessed 2013 Jan 13.
13. Fisson S, Ouakrim H, Touitou V, Baudet S, Ben Abdelwahed R, et al. (2013) Cytokine profile in human eyes: contribution of a new cytokine combination for differential diagnosis between intraocular lymphoma or uveitis. PloS one 8: e52385.
14. Smith JR, Rosenbaum JT, Wilson DJ, Doolittle ND, Siegal T, et al. (2002) Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology 109: 1709-1716.
15. Ohguro N, Hashida N, Tano Y, (2008) Effect of intravitreous rituximab injections in patients with recurrent ocular lesions associated with central nervous system lymphoma. Archives of ophthalmology 126: 1002-1003.
16. Sou R, Ohguro N, Maeda T, Saishin Y, Tano Y, (2008) Treatment of primary intraocular lymphoma with intravitreal methotrexate. Japanese journal of ophthalmology 52: 167-174.
17. Kawamura H, Yasuda N, Kakinoki M, Sawada T, Sawada O, et al. (2009) Interleukin-10 and interleukin-6 in aqueous humor during treatment of vitreoretinal lymphoma with intravitreally injected methotrexate. Ophthalmic research 42: 172-174.
18. Sen HN, Chan CC, Byrnes G, Fariss RN, Nussenblatt RB, et al. (2008) Intravitreal methotrexate resistance in a patient with primary intraocular lymphoma. Ocular immunology and inflammation 16: 29-33.
19. Saleh M, Nikolitch K, Bourcier T, Speeg C, Gaucher D, (2012) Repeated IL-10 measurement in aqueous humor and OCT imaging are valuable tools to monitor intraocular lymphoma treated with intravitreal injections of methotrexate. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 250: 761-764.
20. van Kooij B, Rothova A, Rijkers GT, de Groot-Mijnes JD, (2006) Distinct cytokine and chemokine profiles in the aqueous of patients with uveitis and cystoid macular edema. American journal of ophthalmology 142: 192-194.